Jianqing Ju

1.0k citations
36 papers · 709 indexed · h-index 14
Topics
Lipoproteins and Cardiovascular Health (7 papers)Adipokines, Inflammation, and Metabolic Diseases (5 papers)Heart Failure Treatment and Management (5 papers)
Partner nations
ChinaUnited States

In The Last Decade

Jianqing Ju

36 papers receiving 705 citations

Peers

Jianqing Ju
Comparison fields: 5 of 121
  • Molecular Biology 187
  • Cardiology and Cardiovascular Medicine 140
  • Surgery 117
  • Pulmonary and Respiratory Medicine 98
  • Pharmacology 90
Replace Zhipeng Zhang with:
Zhipeng Zhang China
Xiangdong Yang China
Lihong Li China
Dandan Gong China
Mario Daidone Italy
Najah R. Hadi Iraq
Ling Tu China
Xiang Hu China
Davit Sargsyan United States
Jianqing Ju relative to Zhipeng Zhang China Zhipeng Zhang's profile →
Citations per field
00.5×1.5×
Zhipeng Zhang · 1×
Citations per year

Countries citing papers authored by Jianqing Ju

Since Specialization
Citations

This map shows the geographic impact of Jianqing Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianqing Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianqing Ju more than expected).

Fields of papers citing papers by Jianqing Ju

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianqing Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianqing Ju. The network helps show where Jianqing Ju may publish in the future.

Co-authorship network of co-authors of Jianqing Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Jianqing Ju. A scholar is included among the top collaborators of Jianqing Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianqing Ju. Jianqing Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 29
4 4
5 11
6 8
7 9
8 11
9 4
10 63
11 126
12 15
13 13
14 11
15 7
16 8
17 83
18 10
19 24
20 12

About Jianqing Ju

Jianqing Ju is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Biological Psychiatry, having authored 36 papers that have together received 709 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (7 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Heart Failure Treatment and Management (5 papers). The work is most often cited by research in Pharmacology (60 citations), Complementary and alternative medicine (54 citations) and Cardiology and Cardiovascular Medicine (140 citations). Jianqing Ju has collaborated with scholars based in China and United States. Frequent co-authors include Jingen Li, Luxia Song, Wende Tian, Hao Xu, Yixuan Fan, Runmin Lai, Hao Xu, Tong Wang, Liyan Xu and Jie Zhang. Their work appears in journals such as The American Journal of Cardiology, Frontiers in Immunology and Journal of Ethnopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026